Titre:
  • Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Auteur:Rossi, J-F; van Hoof, Achiel; de Boeck, K; Johnson, S A; Bron, Dominique; Foussard, C; Lister, T A; Berthou, C; Kramer, M.; Littlewood, T J; Marcus, R E; Deconinck, E; Montillo, M; Guibon, O; Tollerfield, S M
Informations sur la publication:Journal of clinical oncology, 22, 7, page (1260-1267)
Statut de publication:Publié, 2004-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Administration, Oral
Adult
Aged
Antimetabolites, Antineoplastic -- therapeutic use
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
Male
Middle Aged
Prospective Studies
Quality of Life
Remission Induction
Retrospective Studies
Safety
Survival Rate
Treatment Outcome
Vidarabine Phosphate -- analogs & derivatives
Vidarabine Phosphate -- therapeutic use
Note générale:Clinical Trial
Clinical Trial, Phase II
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2004.05.012
info:pii/JCO.2004.05.012
info:pmid/15051774